Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Tel Aviv stock indices fall, Teva Pharmaceuticals hits annual high

EditorBrando Bricchi
Published 2024-01-07, 05:26 p/m
© Sivan Farag, Teva PR
USD/ILS
-
EUR/ILS
-
TA125
-
TA35
-
TEVA
-

TEL AVIV - In the latest market movements on the Tel Aviv Stock Exchange, key indices have experienced a downturn, with the Tel Aviv 35 Index closing down by approximately 0.45% and the Tel Aviv 125 Index by 0.80%. Despite the broader market decline, Teva Pharmaceutical Industries (NYSE:TEVA) Ltd stood out with a significant surge in its share price, reaching an annual high.

Energix Renewable Energies was among the companies that saw one of the steepest drops amid the trading session. This varied performance highlights the divergent paths companies within the exchange are currently taking.

The Israeli currency also saw mixed results in the foreign exchange market. The shekel-dollar exchange rate witnessed a marginal increase, while the shekel-euro rate experienced a slight decrease, reflecting subtle shifts in currency valuations that could impact international trading and investor decisions.

Equity trading volumes on the exchange were notably active, with transactions totaling NIS 752 million. This level of activity signals a robust engagement by investors in the market, despite the overall decline in the indices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.